Clinical outcomes of combined anterior and posterior spinal fusion for dystrophic thoracolumbar spinal deformities of neurofibromatosis-1: fate of nonvascularized anterior fibular strut grafts. 2013

Chizuo Iwai, and Hiroshi Taneichi, and Satoshi Inami, and Takashi Namikawa, and Daisaku Takeuchi, and Nakayuki Kato, and Takahiro Iida, and Katsuji Shimizu, and Yutaka Nohara
Department of Orthopedic Surgery, Dokkyo Medical University School of Medicine, Tochigi, Japan.

METHODS Retrospective study. OBJECTIVE To analyze the clinical outcomes of anterior and posterior spinal fusion (APSF) using a fibular strut autograft (FSAG) and to investigate the morphological changes in the reconstructed spinal column of dystrophic deformities in neurofibromatosis (NF)-1. BACKGROUND APSF is desirable for dystrophic deformities in NF-1 with more than 50° of dystrophic kyphosis. There are few reports regarding the clinical outcomes of APSF in which the morphological changes over time of the anterior strut graft have been investigated. METHODS The clinical and radiographic outcomes of APSF with FSAG were investigated in 10 consecutive patients with dystrophic deformity in NF-1. For qualitative and quantitative analyses, the chronological changes in the FSAG configuration, length, and diameter were evaluated. RESULTS The mean follow-up period was 9 years, 9 months (range, 1-30 years). Graft bone erosion and postoperative curve progression were not observed in any patient. In quantitative analyses of the anterior strut, the mean ratio of the latest and immediately postoperative FSAG lengths was 0.98 (0.93-1.09). The mean central/peripheral ratios of the FSAG diameter (central portion/[upper end + lower end]/2) were 1.02 (0.92-1.10) immediately after surgery, and 1.01 (0.92-1.07) at the latest follow-up, with no significant change between these 2 time points (P = 0.937). The mean preoperative cross-sectional area of the apical vertebral body and its mean virtual cross-sectional area at the final follow-up were 3.80 (1.83-5.43) and 4.87 (2.46-7.00) cm(2), respectively, with a significant difference between these 2 parameters (P = 0.0078). The mean final/preoperative ratio was 1.31 (1.10-1.43). CONCLUSIONS APSF with FSAG for dystrophic deformity in NF-1 successfully reconstructed a reliable spinal column with a rich bone stock. The FSAG and surrounding vertebral bodies were free from postoperative erosion due to dystrophic changes and maintained their stability for a long time.

UI MeSH Term Description Entries
D008159 Lumbar Vertebrae VERTEBRAE in the region of the lower BACK below the THORACIC VERTEBRAE and above the SACRAL VERTEBRAE. Vertebrae, Lumbar
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009456 Neurofibromatosis 1 An autosomal dominant inherited disorder (with a high frequency of spontaneous mutations) that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. NF1 is caused by mutations which inactivate the NF1 gene (GENES, NEUROFIBROMATOSIS 1) on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1014-18) There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and NF1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras (RAS PROTEINS). Peripheral Neurofibromatosis,Recklinghausen Disease of Nerve,von Recklinghausen Disease,Cafe-au-Lait Spots with Pulmonic Stenosis,Molluscum Fibrosum,NF1 (Neurofibromatosis 1),Neurofibromatosis I,Neurofibromatosis Type 1,Neurofibromatosis Type I,Neurofibromatosis, Peripheral Type,Neurofibromatosis, Peripheral, NF 1,Neurofibromatosis, Peripheral, NF1,Neurofibromatosis, Type 1,Neurofibromatosis, Type I,Pulmonic Stenosis with Cafe-au-Lait Spots,Recklinghausen Disease, Nerve,Recklinghausen's Disease of Nerve,Recklinghausens Disease of Nerve,Watson Syndrome,von Recklinghausen's Disease,Cafe au Lait Spots with Pulmonic Stenosis,Neurofibromatoses, Peripheral,Neurofibromatoses, Type I,Neurofibromatosis, Peripheral,Peripheral Neurofibromatoses,Pulmonic Stenosis with Cafe au Lait Spots,Syndrome, Watson,Type 1 Neurofibromatosis,Type 1, Neurofibromatosis,Type I Neurofibromatoses,Type I, Neurofibromatosis,von Recklinghausens Disease
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Chizuo Iwai, and Hiroshi Taneichi, and Satoshi Inami, and Takashi Namikawa, and Daisaku Takeuchi, and Nakayuki Kato, and Takahiro Iida, and Katsuji Shimizu, and Yutaka Nohara
August 1984, The Journal of bone and joint surgery. British volume,
Chizuo Iwai, and Hiroshi Taneichi, and Satoshi Inami, and Takashi Namikawa, and Daisaku Takeuchi, and Nakayuki Kato, and Takahiro Iida, and Katsuji Shimizu, and Yutaka Nohara
July 2005, Spine,
Chizuo Iwai, and Hiroshi Taneichi, and Satoshi Inami, and Takashi Namikawa, and Daisaku Takeuchi, and Nakayuki Kato, and Takahiro Iida, and Katsuji Shimizu, and Yutaka Nohara
January 1997, The Journal of bone and joint surgery. British volume,
Chizuo Iwai, and Hiroshi Taneichi, and Satoshi Inami, and Takashi Namikawa, and Daisaku Takeuchi, and Nakayuki Kato, and Takahiro Iida, and Katsuji Shimizu, and Yutaka Nohara
August 2005, Journal of neurosurgery. Spine,
Chizuo Iwai, and Hiroshi Taneichi, and Satoshi Inami, and Takashi Namikawa, and Daisaku Takeuchi, and Nakayuki Kato, and Takahiro Iida, and Katsuji Shimizu, and Yutaka Nohara
May 2021, Clinical spine surgery,
Chizuo Iwai, and Hiroshi Taneichi, and Satoshi Inami, and Takashi Namikawa, and Daisaku Takeuchi, and Nakayuki Kato, and Takahiro Iida, and Katsuji Shimizu, and Yutaka Nohara
January 2015, PloS one,
Chizuo Iwai, and Hiroshi Taneichi, and Satoshi Inami, and Takashi Namikawa, and Daisaku Takeuchi, and Nakayuki Kato, and Takahiro Iida, and Katsuji Shimizu, and Yutaka Nohara
April 2003, Spine,
Chizuo Iwai, and Hiroshi Taneichi, and Satoshi Inami, and Takashi Namikawa, and Daisaku Takeuchi, and Nakayuki Kato, and Takahiro Iida, and Katsuji Shimizu, and Yutaka Nohara
April 2011, Spinal cord,
Chizuo Iwai, and Hiroshi Taneichi, and Satoshi Inami, and Takashi Namikawa, and Daisaku Takeuchi, and Nakayuki Kato, and Takahiro Iida, and Katsuji Shimizu, and Yutaka Nohara
November 2010, Journal of pediatric orthopedics. Part B,
Chizuo Iwai, and Hiroshi Taneichi, and Satoshi Inami, and Takashi Namikawa, and Daisaku Takeuchi, and Nakayuki Kato, and Takahiro Iida, and Katsuji Shimizu, and Yutaka Nohara
September 1990, Spine,
Copied contents to your clipboard!